Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lauren Wurster

Podiatrist, Foot & Ankle Surgery Phoenix, AZ Doctor of Podiatric Medicine

NPI 1306200613 CMS profile 7216788

4212 N 16Th St, Phoenix, AZ 85016

Open in the dashboard

General payments

$7,349

72 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lauren Wurster of Phoenix, AZ is reported in the CMS Open Payments database as having received $7,349 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,210 14
2024 General $2,239 20
2023 General $1,061 13
2022 General $1,224 9
2021 General $393 7
2020 General $32 2
2019 General $1,190 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lauren Wurster
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Lauren Wurster were reported at $1,210. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Lauren Wurster Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $1,190 $389 $118–$1,406 $163
2020 $32 $191 $62–$691 $114
2021 $393 $329 $104–$1,341 $132
2022 $1,224 $419 $125–$1,611 $149
2023 $1,061 $377 $128–$1,164 $160
2024 $2,239 $394 $134–$1,168 $164
2025 $1,210 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $2,437 27 payments
  2. Orthofix Medical, Inc. $1,023 4 payments
  3. ImpactOrtho, Inc. $889 4 payments
  4. Anika Therapeutics, Inc. $790 2 payments
  5. Arthrex, Inc. $640 7 payments
  6. Paratek Pharmaceuticals, Inc. $211 1 payment
  7. Smith+Nephew, Inc. $193 5 payments
  8. Horizon Therapeutics plc $156 4 payments
  9. Organogenesis Inc. $150 3 payments
  10. Nevro Corp. $149 1 payment
  11. Other $711 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $3,816 16 payments
  2. Food and Beverage $3,438 55 payments
  3. Education $96 1 payment
Products named General payments · program years 2019–2025
  1. TL-HEX $855 3 payments
  2. TrueLok Ring Fixation System $855 3 payments
  3. VARIAX $739 6 payments
  4. PROSTEP $714 8 payments
  5. HemiCAP musculoskeletal $440 1 payment
  6. HemiCAP musculoskeletal $350 1 payment
  7. CITREFIX $288 1 payment
  8. PROSTEP MICA $252 3 payments
  9. NUZYRA $211 1 payment
  10. GALAXY Fixation $168 1 payment
  11. Other $2,282 52 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

225

Median for Podiatry: 160

Drug cost

$2,117

Median for Podiatry: $2,368

Branded share of claims

12%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Terbinafine Hcl Generic 58 $863
Gabapentin Generic 27 $369
Diclofenac Sodium Generic 12 $227
Doxycycline Monohydrate Generic 25 $182
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 27 $174
Clindamycin Hcl Generic 11 $139
Meloxicam Generic 35 $84
Ibuprofen Generic 14 $57
Prednisone Generic 16 $23

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$5,850

Medicare's payments for the services billed

Medicare patients

33

Average age 72

Services billed

93

16 women, 17 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 45%
Chronic kidney disease 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record